Skip to main content

Table 4 Hazard ratios (HRs) of disease-free survival and mortality, and corresponding 95% of confidence intervals (CIs), according to histologic subtypes, among 1009 “Triple Negative” breast cancer. Sardinia, Italy 1994–2015

From: Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis

 

Disease-free survival

Overall survival

Univariate analysis

HR (95% CI)

Multivariate analysisa

HR (95% CI)

Univariate analysis

HR (95% CI)

Multivariate analysisa

HR (95% CI)

IBC-NST

1.00b

1.00b

1.00b

1.00b

Lobular

0.68 (0.33–1.39)

0.57 (0.26–1.24)

1.36 (0.79–2.33)

1.06 (0.50–2.25)

Apocrine

1.40 (0.76–2.60)

1.34 (0.71–2.49)

0.77 (0.64–1.76)

0.54 (0.17–1.73)

Adenoid cystic

1.85 (0.46–7.50)

1.20 (0.16–8.69)

Metaplastic

0.85 (0.40–1.83)

0.75 (0.34–1.64)

0.88 (0.39–2.01)

0.60 (0.18–1.96)

Medullary

0.13 (0.01–0.92)

0.12 (0.01–0.87)

0.30 (0.07–1.21)

0.42 (0.10–1.74)

Other

1.44 (0.67–3.09)

1.33 (0.61–2.89)

0.64 (0.20–2.04)

0.17 (0.02–1.28)

  1. aEstimates from multivariate proportional hazard regression model adjusted for age, tumor size and number of positive nodes. Estimates in bold are those significant at the 0.05 level
  2. bReference category